<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>95(7)</volume><submitter>Kasson PM</submitter><pubmed_abstract>Binding of cell surface glycans by influenza hemagglutinin controls viral attachment and infection of host cells. This binding is a three-way interaction between viral proteins, host glycans, and viral glycans; many structural details of this interaction have been difficult to resolve. Here, we use a series of 100-ns molecular dynamics simulations to further analyze available crystallographic data on hemagglutinin-ligand interactions. Based on our simulations, we predict that the viral glycans contact the host glycans within 1-2 residues of the ligand-binding site. We also predict that the glycan-glycan interactions contain both stabilizing and destabilizing components. These predictions suggest a structural means to explain why changes to viral glycosylation alter the efficiency and selectivity of ligand binding. We also predict that the proximity of these interactions to the ligand-binding pocket will impact the binding affinity of small glycomimetic ligands analogous to the influenza neuraminidase inhibitors currently in clinical use.</pubmed_abstract><journal>Biophysical journal</journal><pagination>L48-50</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2547437</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Structural basis for influence of viral glycans on ligand binding by influenza hemagglutinin.</pubmed_title><pmcid>PMC2547437</pmcid><pubmed_authors>Pande VS</pubmed_authors><pubmed_authors>Kasson PM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Structural basis for influence of viral glycans on ligand binding by influenza hemagglutinin.</name><description>Binding of cell surface glycans by influenza hemagglutinin controls viral attachment and infection of host cells. This binding is a three-way interaction between viral proteins, host glycans, and viral glycans; many structural details of this interaction have been difficult to resolve. Here, we use a series of 100-ns molecular dynamics simulations to further analyze available crystallographic data on hemagglutinin-ligand interactions. Based on our simulations, we predict that the viral glycans contact the host glycans within 1-2 residues of the ligand-binding site. We also predict that the glycan-glycan interactions contain both stabilizing and destabilizing components. These predictions suggest a structural means to explain why changes to viral glycosylation alter the efficiency and selectivity of ligand binding. We also predict that the proximity of these interactions to the ligand-binding pocket will impact the binding affinity of small glycomimetic ligands analogous to the influenza neuraminidase inhibitors currently in clinical use.</description><dates><release>2008-01-01T00:00:00Z</release><publication>2008 Oct</publication><modification>2021-02-21T05:58:27Z</modification><creation>2019-03-26T22:31:50Z</creation></dates><accession>S-EPMC2547437</accession><cross_references><pubmed>18641068</pubmed><doi>10.1529/biophysj.108.141507</doi></cross_references></HashMap>